Ostinol Insta Joint

Product Overview

Product Image

Brand: ZyCal Bioceuticals Healthcare

Barcode: 8 57208 00648 4

Net Contents: 30 Capsule(s)

Serving Size (Overview): 1 Capsule(s)

Product Type: Other Combinations [A1325]

Form: Capsule [E0159]

Date Entered: Mar 25, 2025

Market Status: On Market

Suggested Use (Overview): Suggested Use: As a supplement take one (1) to two (2) Ostinol InstaJoint capsules two (2) times per day or as needed.

Product Self-Roles:

  • No specific self-roles defined.

Dietary Supplement Facts

Ingredient Category Amount Per Serving Unit % Daily Value Target Group Serving Size (Fact)
Cyplexinol blend 200 mg N/A Adults and children 4 or more years of age 1 Capsule(s)
3-0-Acetyl-11-Keto Beta-Boswellic Acid non-nutrient/non-botanical 150 mg N/A Adults and children 4 or more years of age 1 Capsule(s)
ApresFlex botanical 50 mg N/A Adults and children 4 or more years of age 1 Capsule(s)

Other Ingredients

Microcrystalline Cellulose; Stearic Acid; Magnesium Stearate (Mg Stearate); Gelatin

Label Statements

Formulation

  • Ostinol InstaJoint contains Cyplexinol Std a natural growth-factor BMP-complex. BMP complexes are functionally involved in the formation of bone and cartilage tissue however limited studies for oral administration are available but ongoing. Additionally Ostinol InstaJoint contains boswellic acid (AKBA) enriched to 65%. ApresFlex a licensed ingredient from PLT Health Solution is added to support joints in as few as 5 days according to their clinical results. AprèsFlex Powered by Cyplexinol Nature's BMP; Complex Improved with ApresFlex 5-day joint support

Suggested Use

  • Suggested Use: As a supplement take one (1) to two (2) Ostinol InstaJoint capsules two (2) times per day or as needed.

Precautions

  • Warning: Consult a healthcare provider before using if pregnant nursing or on medication. Do not use if inner seal is missing or broken. Keep out of the reach of children.

Product Specific Information

  • Store in a cool dry place.

Statement of Identity

  • These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose treat cure or prevent any disease. Dietary Supplement

Branding Statement(s)

  • Patent Nos. 9011930 and 9173905 AprèsFlex is a registered trademark of PLT Health Solutions-Laila Nutraceuticals LLC. ZyCal Bioceuticals Healthcare Co. Innovators in Natural Health

Associated Company Information & Roles

ZyCal Bioceuticals Healthcare Co.

5 Executive Drive Suite A, Toms River, NJ 08755

Roles for this Product:

  • Distributor